SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Monday reported second-quarter net income of $51.3 million, after reporting a loss in the ...
News
- Neurocrine: 2Q Earnings Snapshot
- 6 companies challenge Utah's medical marijuana growing picks
In an appeals letter dated July 26, Utah-based research firm Tintic United Bioscience LLC says the Department of Agriculture violated a "blackout ...
- Pfizer posts big 2Q profit jump, announces deal with Mylan
Among Pfizer's steps since January are the just-completed acquisition of biotech company Therachon Holding AG, to gain an experimental drug that ...
- SELLAS Life Sciences Group, Inc. (SLS) Analysts See $-0.18 EPS
Analysts expect SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) to report $-0.18 EPS on August, 21.They anticipate $1.08 EPS change or 85.71 ...
- Celcuity Inc. (CELC) EPS Estimated At $-0.20
... “Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center – Business Wire” on October 16, 2018. ... at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast ...